Do you support this bill?

Senate Bill S10711

2025-2026 Legislative Session

Requires certain physicians or other authorized practitioners to offer prenatal testing for antiphospholipid syndrome

download bill text pdf

Sponsored By

Current Bill Status - In Senate Committee Rules Committee

Please enter your contact information

Home address is used to determine the senate district in which you reside. Your support or opposition to this bill is then shared immediately with the senator who represents you.

Optional services from the NY State Senate:

Create an account. An account allows you to officially support or oppose key legislation, sign petitions with a single click, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.

Include a custom message for your Senator? (Optional)

Enter a message to your senator. Many New Yorkers use this to share the reasoning behind their support or opposition to the bill. Others might share a personal anecdote about how the bill would affect them or people they care about.

Actions

2025-S10711 (ACTIVE) - Details

Current Committee:
Senate Rules
Law Section:
Public Health Law
Laws Affected:
Add §2533, Pub Health L

2025-S10711 (ACTIVE) - Summary

Requires every physician or other authorized practitioner attending pregnant persons in this state to offer prenatal testing for antiphospholipid syndrome as part of routine prenatal care.

2025-S10711 (ACTIVE) - Bill Text download pdf 

                             
                     S T A T E   O F   N E W   Y O R K
 ________________________________________________________________________
 
                                   10711
 
                             I N  S E N A T E
 
                            September 30, 2026
                                ___________
 
 Introduced  by Sen. SCARCELLA-SPANTON -- read twice and ordered printed,
   and when printed to be committed to the Committee on Rules
 
 AN ACT to amend the public health law, in relation to requiring  certain
   physicians or other authorized practitioners to offer prenatal testing
   for antiphospholipid syndrome
 
   THE  PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM-
 BLY, DO ENACT AS FOLLOWS:
 
   Section 1. The public health law is amended by adding  a  new  section
 2533 to read as follows:
   §  2533.  PRENATAL  TESTING  FOR  ANTIPHOSPHOLIPID  SYNDROME. 1. EVERY
 PHYSICIAN OR OTHER AUTHORIZED PRACTITIONER ATTENDING PREGNANT PERSONS IN
 THIS STATE SHALL OFFER BLOOD TESTING FOR  ANTIPHOSPHOLIPID  SYNDROME  AS
 PART OF ROUTINE PRENATAL CARE.
   2.  THE  COMMISSIONER MAY PROMULGATE SUCH RULES AND REGULATIONS AS ARE
 NECESSARY TO CARRY OUT THE REQUIREMENTS OF THIS SECTION.
   § 2. This act shall take effect on the ninetieth day  after  it  shall
 have become a law.
 
 
 
 
 
 
  EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets
                       [ ] is old law to be omitted.
                                                            LBD16409-02-6

Comments

Open Legislation is a forum for New York State legislation. All comments are subject to review and community moderation is encouraged.

Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity, hate or toxic speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Attempts to intimidate and silence contributors or deliberately deceive the public, including excessive or extraneous posting/posts, or coordinated activity, are prohibited and may result in the temporary or permanent banning of the user. Comment moderation is generally performed Monday through Friday. By contributing or voting you agree to the Terms of Participation and verify you are over 13.

Create an account. An account allows you to sign petitions with a single click, officially support or oppose key legislation, and follow issues, committees, and bills that matter to you. When you create an account, you agree to this platform's terms of participation.